Litcius/Paper detail

Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial

Kevin Talboom, Wernard A. A. Borstlap, Sapho X. Roodbeen, Emma R.J. Bruns, Christianne J. Buskens, Roel Hompes, Kristien M.A.J. Tytgat, Jurriaan B. Tuynman, Esther C. J. Consten, Gijsbert Heuff, Teaco Kuiper, Anna A. W. van Geloven, G.J. Veldhuis, Joost A.B. van der Hoeven, S. M. M. de Castro, Colin Sietses, Antonino Spinelli, Anthony W. H. van de Ven, Edwin S. van der Zaag, Marinke Westerterp, Henderik L. van Westreenen, Marcel L Dijkgraaf, Nicole P. Juffermans, Wilhelmus A. Bemelman, Annette A. van Zweeden, Daniel Heß, Hilko A. Swank, L. Scholten, Jarmila D.W. van der Bilt, Marilou Jansen, Peter van Duijvendijk, Donna Bezuur, Michele Carvello, Caterina Foppa, Wouter H. de Vos tot Nederveen Cappel, Ritch Geitenbeek, Lara van Woensel, S. M. M. de Castro, Caroline Wientjes, Stefan van Oostendorp

2023The Lancet Haematology73 citationsDOIOpen Access PDF

Topics & Concepts

MedicineIron deficiencyAdverse effectClinical endpointInternal medicineAnemiaColorectal cancerTransferrin saturationConcomitantTolerabilityGastroenterologySurgeryRandomized controlled trialCancerIron Metabolism and DisordersBlood transfusion and managementErythropoietin and Anemia Treatment
Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial | Litcius